Search results
Showing 1396 to 1410 of 1688 results for carers
The Arrow OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy (MIB19)
NICE has developed a Medtech Innovation Briefing (MIB) on the ARROW OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy
This quality standard covers assessing and managing trauma (complex fractures, non-complex fractures, major trauma and spinal injury) in adults, young people and children. It describes high-quality care in priority areas for improvement.
View quality statements for QS166Show all sections
Sections for QS166
expertise of the royal medical colleges, professional bodies and patient/carer organisations. 2002 First clinical guideline CG1...
Summary of the evidence on topical timolol for treating infantile haemangioma (strawberry marks) to inform local NHS planning and decision-making
Nivolumab for previously treated advanced hepatocellular carcinoma [ID1141]
Discontinued [GID-TA10164]
Evidence-based recommendations on rimegepant (Vydura) for preventing migraine in adults.
Ibrutinib for treating relapsed or refractory mantle cell lymphoma (TA502)
Evidence-based recommendations on ibrutinib (Imbruvica) for treating relapsed or refractory mantle cell lymphoma in adults.
Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma (TA319)
Evidence-based recommendations on ipilimumab (Yervoy) for previously untreated advanced (unresectable or metastatic) melanoma in adults.
Discontinued [GID-TA10133]
comments on the assessment report submissions from the professional, patient/carer and NHS commissioning consultees summaries of the...
This quality standard covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It describes high-quality care in priority areas for improvement.
View quality statements for QS208Show all sections
Sections for QS208
- Quality statements
- Quality statement 1: Structured education programmes
- Quality statement 2: Continuous glucose monitoring
- Quality statement 3: Statin therapy for primary prevention of cardiovascular disease
- Quality statement 4: 9 key care processes
- Quality statement 5: Assessing the risk of diabetic foot problems on admission to hospital
- Quality statement 6: Support to self-manage diabetes during inpatient admissions
- Quality statement 7 (placeholder): Identification of eating disorders in adults with type 1 diabetes
Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603]
Discontinued [GID-TA10711]
Anamorelin for treating anorexia and cachexia associated with non-small cell lung cancer [ID821]
Discontinued [GID-TA10105]
Discontinued [GID-TA10109]